CZ299817B6 - Nové pentasacharidy, zpusob jejich prípravy a farmaceutické kompozice, které je obsahují - Google Patents

Nové pentasacharidy, zpusob jejich prípravy a farmaceutické kompozice, které je obsahují Download PDF

Info

Publication number
CZ299817B6
CZ299817B6 CZ20002636A CZ20002636A CZ299817B6 CZ 299817 B6 CZ299817 B6 CZ 299817B6 CZ 20002636 A CZ20002636 A CZ 20002636A CZ 20002636 A CZ20002636 A CZ 20002636A CZ 299817 B6 CZ299817 B6 CZ 299817B6
Authority
CZ
Czechia
Prior art keywords
methyl
tri
sulfo
glucopyranosyl
acid
Prior art date
Application number
CZ20002636A
Other languages
Czech (cs)
English (en)
Other versions
CZ20002636A3 (cs
Inventor
Petitou@Maurice
Original Assignee
Sanofi-Aventis
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sanofi-Aventis filed Critical Sanofi-Aventis
Publication of CZ20002636A3 publication Critical patent/CZ20002636A3/cs
Publication of CZ299817B6 publication Critical patent/CZ299817B6/cs

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H15/00—Compounds containing hydrocarbon or substituted hydrocarbon radicals directly attached to hetero atoms of saccharide radicals
    • C07H15/02—Acyclic radicals, not substituted by cyclic structures
    • C07H15/04—Acyclic radicals, not substituted by cyclic structures attached to an oxygen atom of the saccharide radical
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08B—POLYSACCHARIDES; DERIVATIVES THEREOF
    • C08B37/00—Preparation of polysaccharides not provided for in groups C08B1/00 - C08B35/00; Derivatives thereof
    • C08B37/006—Heteroglycans, i.e. polysaccharides having more than one sugar residue in the main chain in either alternating or less regular sequence; Gellans; Succinoglycans; Arabinogalactans; Tragacanth or gum tragacanth or traganth from Astragalus; Gum Karaya from Sterculia urens; Gum Ghatti from Anogeissus latifolia; Derivatives thereof
    • C08B37/0063—Glycosaminoglycans or mucopolysaccharides, e.g. keratan sulfate; Derivatives thereof, e.g. fucoidan
    • C08B37/0075—Heparin; Heparan sulfate; Derivatives thereof, e.g. heparosan; Purification or extraction methods thereof
    • C08B37/0078—Degradation products

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Medicinal Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Genetics & Genomics (AREA)
  • Biotechnology (AREA)
  • Hematology (AREA)
  • Polymers & Plastics (AREA)
  • Materials Engineering (AREA)
  • Diabetes (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
CZ20002636A 1998-01-19 1999-01-13 Nové pentasacharidy, zpusob jejich prípravy a farmaceutické kompozice, které je obsahují CZ299817B6 (cs)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR9800514A FR2773801B1 (fr) 1998-01-19 1998-01-19 Nouveaux pentasaccharides, procedes pour leurs preparations et compositions pharmaceutiques les contenant

Publications (2)

Publication Number Publication Date
CZ20002636A3 CZ20002636A3 (cs) 2000-11-15
CZ299817B6 true CZ299817B6 (cs) 2008-12-03

Family

ID=9521913

Family Applications (1)

Application Number Title Priority Date Filing Date
CZ20002636A CZ299817B6 (cs) 1998-01-19 1999-01-13 Nové pentasacharidy, zpusob jejich prípravy a farmaceutické kompozice, které je obsahují

Country Status (38)

Country Link
US (1) US6670338B1 (enExample)
EP (1) EP1049706B1 (enExample)
JP (1) JP4695756B2 (enExample)
KR (1) KR100533565B1 (enExample)
CN (1) CN1172948C (enExample)
AR (1) AR012779A1 (enExample)
AT (1) ATE241637T1 (enExample)
AU (1) AU744137B2 (enExample)
BR (1) BR9907100B1 (enExample)
CA (1) CA2318326C (enExample)
CO (1) CO4970823A1 (enExample)
CZ (1) CZ299817B6 (enExample)
DE (1) DE69908298T2 (enExample)
DK (1) DK1049706T3 (enExample)
DZ (1) DZ2706A1 (enExample)
EE (1) EE04194B1 (enExample)
EG (1) EG23760A (enExample)
ES (1) ES2200494T3 (enExample)
FR (1) FR2773801B1 (enExample)
GT (1) GT199900006A (enExample)
HR (1) HRP20000479A8 (enExample)
HU (1) HU228335B1 (enExample)
IL (2) IL137240A0 (enExample)
MY (1) MY125636A (enExample)
NO (1) NO316894B1 (enExample)
NZ (1) NZ505614A (enExample)
PL (1) PL191098B1 (enExample)
PT (1) PT1049706E (enExample)
RU (1) RU2193040C2 (enExample)
SA (1) SA99191114B1 (enExample)
SI (1) SI1049706T1 (enExample)
SK (1) SK284176B6 (enExample)
TR (1) TR200002077T2 (enExample)
TW (1) TW550267B (enExample)
UA (1) UA61124C2 (enExample)
UY (1) UY25357A1 (enExample)
WO (1) WO1999036428A1 (enExample)
ZA (1) ZA99357B (enExample)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2814463B1 (fr) * 2000-09-22 2002-11-15 Sanofi Synthelabo Nouveaux polysaccharides a activite antithrombotique comprenant au moins une liaison covalente avec la biotine ou un derive de la biotine
CN100513398C (zh) 2002-12-03 2009-07-15 Axys药物公司 作为因子viia抑制剂的2-(2-羟基联苯-3-基)-1h-苯并咪唑-5-甲脒衍生物
KR101156273B1 (ko) * 2004-03-04 2012-06-13 프로젠 파마슈티칼즈 리미티드 황산화 올리고사카라이드 유도체
CN100338084C (zh) * 2004-07-02 2007-09-19 北京大学 抑制异种器官移植免疫排斥反应的五糖抗原的合成方法
FR2874924B1 (fr) 2004-09-09 2006-12-01 Sanofi Aventis Sa Hexadecasaccharides biotinyles, leur preparation et leur utilisation therapeutique
TWI403334B (zh) 2004-12-23 2013-08-01 Merck Sharp & Dohme 包含生物素殘基之抗血栓雙重抑制劑
TWI376234B (en) * 2005-02-01 2012-11-11 Msd Oss Bv Conjugates of a polypeptide and an oligosaccharide
US20070191306A1 (en) * 2005-08-17 2007-08-16 Bristol-Myers Squibb Company FACTOR Xa INHIBITOR FORMULATION AND METHOD
EP1908768A1 (en) * 2006-10-05 2008-04-09 Endotis Pharma Anticoagulant compounds
CN102046781A (zh) 2008-05-30 2011-05-04 动量制药公司 糖结构以及制造和使用此类结构的方法
WO2010029552A1 (en) * 2008-09-10 2010-03-18 Transpharma Medical Ltd. Transdermal delivery of oligosaccharides
WO2011014793A2 (en) * 2009-07-31 2011-02-03 Reliable Biopharmaceutical Corporation Process for preparing fondaparinux sodium and intermediates useful in the synthesis thereof
US8420790B2 (en) 2009-10-30 2013-04-16 Reliable Biopharmaceutical Corporation Efficient and scalable process for the manufacture of Fondaparinux sodium
CN103917552B (zh) * 2011-06-17 2017-03-29 卡博梅麦特斯公司 具有短半衰期和高活性的合成五糖

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0301618A2 (en) * 1987-07-20 1989-02-01 Akzo N.V. New pentasaccharides
CZ16099A3 (cs) * 1996-07-19 1999-06-16 Sanofi Syntetické polysacharidy, způsob jejich přípravy a farmaceutické kompozice s jejich obsahem

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK0454220T3 (da) * 1990-04-23 1993-11-22 Sanofi Elf Carbohydratderivater omfattende en trisaccharidenhed
IL102758A (en) * 1991-08-23 1997-03-18 Akzo Nv Glycosaminoglycanoid derivatives, their preparation and pharmaceutical compositions comprising them
FR2704226B1 (fr) * 1993-04-22 1995-07-21 Sanofi Elf 3-desoxy oligosaccharides, leurs procedes de preparation et les compositions pharmaceutiques qui les contiennent.
ES2147216T3 (es) * 1993-09-01 2000-09-01 Akzo Nobel Nv Bisconjugados que comprenden dos sacaridos y un grupo de union.

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0301618A2 (en) * 1987-07-20 1989-02-01 Akzo N.V. New pentasaccharides
CZ16099A3 (cs) * 1996-07-19 1999-06-16 Sanofi Syntetické polysacharidy, způsob jejich přípravy a farmaceutické kompozice s jejich obsahem

Also Published As

Publication number Publication date
CA2318326A1 (en) 1999-07-22
IL137240A0 (en) 2001-07-24
UA61124C2 (en) 2003-11-17
SI1049706T1 (en) 2003-12-31
ES2200494T3 (es) 2004-03-01
RU2193040C2 (ru) 2002-11-20
EE200000421A1 (et) 2003-06-16
CN1172948C (zh) 2004-10-27
PL191098B1 (pl) 2006-03-31
HUP0102042A1 (hu) 2001-10-28
EP1049706B1 (fr) 2003-05-28
GT199900006A (es) 2000-07-12
HUP0102042A3 (en) 2003-07-28
HU228335B1 (en) 2013-03-28
AU1974699A (en) 1999-08-02
DZ2706A1 (fr) 2003-09-01
DE69908298T2 (de) 2004-04-01
NZ505614A (en) 2003-02-28
FR2773801B1 (fr) 2000-05-12
PL341874A1 (en) 2001-05-07
IL137240A (en) 2007-10-31
NO316894B1 (no) 2004-06-14
JP4695756B2 (ja) 2011-06-08
EE04194B1 (et) 2003-12-15
ZA99357B (en) 2000-07-19
MY125636A (en) 2006-08-30
US6670338B1 (en) 2003-12-30
DE69908298D1 (de) 2003-07-03
HRP20000479A2 (en) 2001-02-28
PT1049706E (pt) 2003-09-30
KR100533565B1 (ko) 2005-12-06
AU744137B2 (en) 2002-02-14
ATE241637T1 (de) 2003-06-15
HRP20000479B8 (hr) 2025-09-12
TW550267B (en) 2003-09-01
CO4970823A1 (es) 2000-11-07
AR012779A1 (es) 2000-11-08
CA2318326C (en) 2010-07-06
SK284176B6 (sk) 2004-10-05
EP1049706A1 (fr) 2000-11-08
FR2773801A1 (fr) 1999-07-23
CN1293679A (zh) 2001-05-02
CZ20002636A3 (cs) 2000-11-15
NO20003661L (no) 2000-09-19
UY25357A1 (es) 2000-12-29
BR9907100B1 (pt) 2013-09-03
SA99191114B1 (ar) 2006-10-11
JP2002509154A (ja) 2002-03-26
KR20010034205A (ko) 2001-04-25
HRP20000479A8 (hr) 2025-09-12
NO20003661D0 (no) 2000-07-17
WO1999036428A1 (fr) 1999-07-22
DK1049706T3 (da) 2003-09-29
HK1029999A1 (zh) 2001-04-20
TR200002077T2 (tr) 2000-12-21
SK10792000A3 (sk) 2001-01-18
EE200000421A (et) 2001-12-17
BR9907100A (pt) 2000-10-24
HRP20000479B1 (hr) 2006-04-30
EG23760A (en) 2007-08-08

Similar Documents

Publication Publication Date Title
US6534481B1 (en) Synthetic polysaccharides, preparation method therefor and pharmaceutical compositions containing same
JP3594990B2 (ja) ３−デオキシオリゴ糖、その製造方法およびそれを含有する医薬組成物
KR100533565B1 (ko) 신규한 오당류, 이의 제조방법 및 이를 포함하는 제약 조성물
DE69900718T2 (de) Synthetische polysaccharide, verfahren zu deren herstellung und diese enthaltende pharmazeutische zusammensetzungen
HU226685B1 (en) Carbohydrate derivatives and pharmaceutical compns. contg. them
JP3501813B2 (ja) 合成ポリサッカライド、それらの製造法およびそれらを含む医薬組成物
HK1029999B (en) New pentasaccharides, their methods of production and pharmaceutical compositions containing same

Legal Events

Date Code Title Description
MM4A Patent lapsed due to non-payment of fee

Effective date: 20180113